Private Equity

After a four-year regulatory journey, AquaBoreal's massive salmon farm gets key approval, promising to boost Quebec's food security and revitalize a region.

A fast-growing dental group is slashing legal costs and speeding up deals with a new platform, turning acquisitions into a data-driven science.

For millions with disabilities, a simple ride is a lifeline. One company is turning a logistical nightmare into a path to independence and essential care.

The Blackstone-backed energy data giant adds AI-driven engineering automation, signaling a major push to digitize and modernize critical utility infrastructure.

Backed by JLL Partners, new platform Talica aims to unify the fragmented but vital surface science market for aerospace, pharma, and other high-tech industries.

Kulicke & Soffa's consistent dividend underscores its financial health and strategic position in the booming AI, automotive, and advanced packaging markets.

With strong revenue growth and critical FDA decisions on the horizon, MannKind's leadership prepares to outline its vision for investors in Miami.

With a tenfold increase in volunteer hours since 2021, energy giant Avangrid is redefining corporate citizenship, linking community service to its core strategy.

Ready-mix concrete firm Suncrete clears a key hurdle for its Nasdaq debut via SPAC, backed by a $105.5M investment to fuel its Sunbelt expansion.

A new poll reveals overwhelming public opposition to a federal plan to stockpile glyphosate, fueled by billions in lawsuits and a retracted safety study.

With a landmark $407M deal, Surf Internet is set to supercharge fiber deployment in underserved communities, signaling a new era for rural connectivity.

The PGA TOUR partners with Supergoop! in a landmark deal, positioning sun protection as a key to performance and public health for millions of fans.

A reported 18% jump in chemicals M&A value masks a market driven by defense, not growth, as tariffs and portfolio pressures reshape the industry.

Data shows Achieve Life Sciences' drug helps smokers quit, even after multiple failed attempts with other drugs, as a critical FDA decision looms.

For the second straight year, Edison Partners earned a top PE innovator award. We explore the 'Edison Edge' platform driving its sustained success.

Fresh off a blockbuster IPO, SpyGlass Pharma heads to a key investor summit. Can its revolutionary long-acting drug platform transform chronic eye care?

As its stock stumbles, web-game leader CTW heads to the Roth Conference to prove its unique anime IP and HTML5 model can deliver long-term growth.

Avetta lands on The Hackett Group's prestigious '50 to Know' list, a key validation of its AI-powered approach in a crowded procurement tech market.

Azio AI reports progress on a massive $107M GPU order, but with only 13% in deposits, is it enough to secure its crucial merger with Envirotech Vehicles?

Despite a full-year GAAP loss, AFC declares a dividend and shifts its strategy post-BDC conversion. Can it resolve legacy loans and find new growth?